Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present PTC Therapeutics, Inc. (NASDAQ: PTCT).

Full DD Report for PTCT

You must become a subscriber to view this report.


Recent News from (NASDAQ: PTCT)

FDA accepts Novartis' marketing application for SMA Type 1 gene therapy AVXS-101
The FDA accepts under Priority Review Novartis' (NYSE: NVS ) marketing application seeking approval for gene therapy AVXS-101 for the treatment of spinal muscular atrophy (SMA) Type 1. The agency's action date is in May 2019. More news on: Novartis AG, Biogen Inc., Ionis Pharmaceuticals,...
Source: SeekingAlpha
Date: December, 03 2018 07:32
PTC Therapeutics (PTCT) CEO Stuart Peltz on Q3 2018 Results - Earnings Call Transcript
PTC Therapeutics (PTCT) Q3 2018 Results Earnings Conference Call November 05, 2018, 04:30 PM ET Executives Emily Hill - Head of Investor Relations Stuart Peltz - Chief Executive Officer Marcio Souza - Chief Operating Officer Christine Utter - Principal Financial Officer and Tre...
Source: SeekingAlpha
Date: November, 05 2018 23:14
PTC Therapeutics 2018 Q3 - Results - Earnings Call Slides
The following slide deck was published by PTC Therapeutics in conjunction with their 2018 Q3 earnings Read more ...
Source: SeekingAlpha
Date: November, 05 2018 17:09
PTC Therapeutics misses by $0.59, misses on revenue
PTC Therapeutics (NASDAQ: PTCT ): Q3 GAAP EPS of -$1.06 misses by $0.59 . Revenue of $53.6M (+27.9% Y/Y) misses by $17.3M . Press Release More news on: PTC Therapeutics, Earnings news and commentary, Healthcare stocks news,
Source: SeekingAlpha
Date: November, 05 2018 16:06
PTC Therapeutics Reports Third Quarter 2018 Financial Results and Provides a Corporate Update
SOUTH PLAINFIELD, N.J. , Nov. 5, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the third quarter ending September 30, 2018 . "We have been aggressively pursuing our vision to build a leading, fully inte...
Source: PR Newswire
Date: November, 05 2018 16:01
Notable earnings after Monday's close
ACHC , AEL , AKCA , ANDE , APLE , APTS , ATRO , ATUS , AVD , AWR , BE , BHF , BKD , BKH , BKNG , CAR , CBT , CDEV , COHU , CRZO , CTRE , CXW , DCO , DCP , DRH , DVAX , ELF , EVBG , FMC , FN , FNV , FRGI , FRPT , FTDR , HHC , IFF , INSY , IPAR , ITRI , ...
Source: SeekingAlpha
Date: November, 04 2018 17:35
PTC Therapeutics to Participate at Upcoming Investor Conference
SOUTH PLAINFIELD, N.J. , Oct. 30, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the Credit Suisse 27 th Annual Healthcare Conference on Tuesday, November 13 th at 10:55 a.m. MST .   The pre...
Source: PR Newswire
Date: October, 30 2018 08:00
PTC Therapeutics Announces Winners of Global Duchenne Muscular Dystrophy Patient Group STRIVE Awards in Recognition of World Duchenne Awareness Day
SOUTH PLAINFIELD, N.J. , Sept. 7, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) is pleased to announce the recipients of the Company's 2018 global STRIVE Awards (Strategies to Realize Innovation, Vision and Empowerment) program, designed to support nonprofit organizations ser...
Source: PR Newswire
Date: September, 07 2018 08:00
Today's Research Reports on Trending Tickers: bluebird bio and PTC Therapeutics
NEW YORK, NY / ACCESSWIRE / September 7, 2018 / U.S. benchmarks closed mostly lower on Thursday, with the Dow Jones remaining in the green, as internet and tech shares slumped. The Dow Jones Industrial Average was up 0.08 percent to close at 25,995.87, while the S&P 500 Index decreased 0...
Source: ACCESSWIRE IA
Date: September, 07 2018 08:00
Exonics Therapeutics' gene editing approach shows encouraging action in DMD model
Privately-held Exonics Therapeutics announces that its SingleCut CRISPR gene editing technology restored dystrophin expression in a canine model of Duchenne muscular dystrophy (DMD). The results were just published online in Science . More news on: Sarepta Therapeutics, Inc., Cata...
Source: SeekingAlpha
Date: August, 30 2018 15:58

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1447.2647.3348.2546.78948,647
2017-03-0610.3010.2210.549.713,114,338
2017-03-0310.849.8110.869.6353,096,160
2017-03-0211.0110.5812.0510.257,638,749
2017-03-0113.9013.1814.432512.86031,258,278

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-0758,219230,18225.2926Cover
2018-12-0653,702153,52034.9805Cover
2018-12-0497,843140,23669.7702Short
2018-12-0383,374113,13573.6943Short
2018-11-3092,943351,20526.4640Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on PTCT.


About PTC Therapeutics, Inc. (NASDAQ: PTCT)

Logo for PTC Therapeutics, Inc. (NASDAQ: PTCT)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: PTCT)

      Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act
      Filing Type: DFiling Source: edgar
      Filing Date: September, 05 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 28 2018
      Filing Type: CT ORDERFiling Source: edgar
      Filing Date: August, 27 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 24 2018
      Automatic shelf registration statement of securities of well-known seasoned issuers
      Filing Type: S-3ASRFiling Source: edgar
      Filing Date: August, 24 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 07 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: August, 07 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 02 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: July, 27 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: July, 19 2018

       

       


      Daily Technical Chart for (NASDAQ: PTCT)

      Daily Technical Chart for (NASDAQ: PTCT)


      Stay tuned for daily updates and more on (NASDAQ: PTCT)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: PTCT)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in PTCT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of PTCT and does not buy, sell, or trade any shares of PTCT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/